Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

CT (computed tomography) contrast agents may harm lung injury patients:

This article was originally published in Clinica

Executive Summary

Injecting a contrast agent into the lungs of patients with acute lung injury (ALI) during investigative CT scans may worsen the severity of their condition, say US researchers. A 14-patient study found that injecting CT-contrast dye into patients with ALI, a disorder characterised by widespread destruction of lung tissue and a reduction of oxygen levels in the blood, causes the accumulation of fluid in the lungs. This can make it more difficult to breathe, which is particularly risky for already critically ill patients, the researchers report in Critical Care (December 16).

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT069327

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel